SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001136261-19-000019
Filing Date
2019-01-31
Accepted
2019-01-31 16:16:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D sc13d.htm SC 13D 18007
  Complete submission text file 0001136261-19-000019.txt   19431
Mailing Address 300 PARK AVENUE NEW YORK NY 10017
Business Address 300 PARK AVENUE NEW YORK NY 10017 (646) 998-6475
SEELOS THERAPEUTICS, INC. (Subject) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-53409 | Film No.: 19556099
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SEELOS THERAPEUTICS, INC. 300 PARK AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address
Mehra Raj (Filed by) CIK: 0001757892 (see all company filings)

Type: SC 13D